(82) revealed that prostate-specific membrane antigen (PSMA) was also expressed on the sEV membrane in the plasma of patients with prostate cancer, which might be used to isolate prostate cancer-related sEVs from blood samples. Here, FOLH1 is linked to prostate carcinoma.